Carderock Capital Management Inc. Acquires 964 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Carderock Capital Management Inc. increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 11,414 shares of the healthcare conglomerate’s stock after acquiring an additional 964 shares during the period. Carderock Capital Management Inc.’s holdings in UnitedHealth Group were worth $6,674,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of UNH. Harbor Investment Advisory LLC lifted its stake in UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after acquiring an additional 1,129 shares during the last quarter. Austin Private Wealth LLC raised its stake in UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after buying an additional 111 shares during the period. Capital Insight Partners LLC increased its holdings in shares of UnitedHealth Group by 3.8% during the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after acquiring an additional 332 shares during the last quarter. Collective Family Office LLC lifted its holdings in UnitedHealth Group by 4.3% during the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after purchasing an additional 65 shares during the last quarter. Finally, Global Assets Advisory LLC acquired a new position in shares of UnitedHealth Group in the first quarter valued at $282,469,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 2.7 %

UnitedHealth Group stock opened at $571.30 on Thursday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The firm has a market capitalization of $527.55 billion, a price-to-earnings ratio of 37.88, a P/E/G ratio of 1.69 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a 50 day simple moving average of $584.21 and a 200 day simple moving average of $532.84.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.56 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Robert W. Baird upped their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Stephens dropped their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday. Royal Bank of Canada reduced their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday. HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Finally, TD Cowen upped their target price on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $615.16.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.